Cargando…

Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis

BACKGROUND: Ibrutinib and acalabrutinib are Bruton tyrosine kinase inhibitors used in the treatment of B‐cell lymphoproliferative disorders. Ibrutinib is associated with new‐onset atrial fibrillation. Cases of sinus bradycardia and sinus arrest have also been reported following ibrutinib treatment....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuomi, Jari M., Bohne, Loryn J., Dorey, Tristan W., Jansen, Hailey J., Liu, Yingjie, Jones, Douglas L., Rose, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751944/ https://www.ncbi.nlm.nih.gov/pubmed/34726066 http://dx.doi.org/10.1161/JAHA.121.022369

Ejemplares similares

Electrophysiological and Molecular Mechanisms of Sinoatrial Node Mechanosensitivity
por: Turner, Daniel, et al.
Publicado: (2021)

Profound Sinoatrial Arrest Associated with Ibrutinib
por: Mathur, Kanupriya, et al.
Publicado: (2017)

Impaired regulation of heart rate and sinoatrial node function by the parasympathetic nervous system in type 2 diabetic mice
por: Liu, Yingjie, et al.
Publicado: (2021)

Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
por: Series, Jennifer, et al.
Publicado: (2019)

Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib
por: Bye, Alexander P., et al.
Publicado: (2022)

Distinct Patterns of Constitutive Phosphodiesterase Activity in Mouse Sinoatrial Node and Atrial Myocardium
por: Hua, Rui, et al.
Publicado: (2012)

Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease
por: Jansen, Hailey J., et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
por: Bohne, Loryn J., et al.
Publicado: (2023)

Effects of Adrenomedullin on Atrial Electrophysiology and Pulmonary Vein Arrhythmogenesis
por: Chin, Chye-Gen, et al.
Publicado: (2022)

Atrial structure, function and arrhythmogenesis in aged and frail mice
por: Jansen, Hailey J., et al.
Publicado: (2017)

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2023)

Sinoatrial Node Structure, Mechanics, Electrophysiology and the Chronotropic Response to Stretch in Rabbit and Mouse
por: MacDonald, Eilidh A., et al.
Publicado: (2020)

Evaluation of non-linear heart rate variability using multi-scale multi-fractal detrended fluctuation analysis in mice: Roles of the autonomic nervous system and sinoatrial node
por: Moghtadaei, Motahareh, et al.
Publicado: (2022)

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice
por: Mackasey, Martin, et al.
Publicado: (2018)

The Role of TRPM4 in Cardiac Electrophysiology and Arrhythmogenesis
por: Hu, Yaopeng, et al.
Publicado: (2023)

Leptin modulates electrophysiological characteristics and isoproterenol-induced arrhythmogenesis in atrial myocytes
por: Lin, Yung-Kuo, et al.
Publicado: (2013)

Atrial and Sinoatrial Node Development in the Zebrafish Heart
por: Martin, Kendall E., et al.
Publicado: (2021)

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies
por: Zhu, Sining, et al.
Publicado: (2021)

Circadian rhythm of cardiac electrophysiology, arrhythmogenesis, and the underlying mechanisms
por: Black, Nicholas, et al.
Publicado: (2019)

Electrophysiological Mechanisms of Gastrointestinal Arrhythmogenesis: Lessons from the Heart
por: Tse, Gary, et al.
Publicado: (2016)

Electrophysiological Mechanisms Underlying T-Wave Alternans and Their Role in Arrhythmogenesis
por: You, Tingting, et al.
Publicado: (2021)

Telocytes in the human sinoatrial node
por: Mitrofanova, Lubov B., et al.
Publicado: (2017)

Molecular and Electrophysiological Mechanisms Underlying Cardiac Arrhythmogenesis in Diabetes Mellitus
por: Tse, Gary, et al.
Publicado: (2016)

Function and Dysfunction of Human Sinoatrial Node
por: Joung, Boyoung, et al.
Publicado: (2015)

Genetic Complexity of Sinoatrial Node Dysfunction
por: Wallace, Michael J., et al.
Publicado: (2021)

Lithium-Induced Sinoatrial Node Dysfunction
por: Sarangi, Ashish, et al.
Publicado: (2021)

Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets – Beyond B Lymphocytes
por: Zhu, Sining, et al.
Publicado: (2021)

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
por: Byrd, John C., et al.
Publicado: (2021)

Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial
por: Seymour, John F., et al.
Publicado: (2023)

The Calcium and Voltage Clocks in Sinoatrial Node Automaticity
por: Joung, Boyoung, et al.
Publicado: (2009)

CaMKII in sinoatrial node physiology and dysfunction
por: Wu, Yuejin, et al.
Publicado: (2014)

Sinoatrial Node Disease in Adults with Down’s Syndrome.
por: Kennedy, J, et al.
Publicado: (2018)

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
por: Nicolson, Phillip L.R., et al.
Publicado: (2018)

Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib
por: Qin, Jim S., et al.
Publicado: (2020)

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
por: Shadman, Mazyar, et al.
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3
por: Morell, Anselm, et al.
Publicado: (2020)

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib
por: Estupiñán, H. Yesid, et al.
Publicado: (2021)

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
por: Lu, Xiaoxiao, et al.
Publicado: (2023)

Is sodium current present in human sinoatrial node cells?
por: Verkerk, Arie O., et al.
Publicado: (2009)

Modeling the Chronotropic Effect of Isoprenaline on Rabbit Sinoatrial Node
por: Zhang, Henggui, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kdiqps9u8p3kro6cbmctg24fjp